Señales en vivo de SCLXW | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -0.25% compare to its pairs and should correct downwards.

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain...

Stats
Volumen de hoy	93 590
Volumen promedio	0
Capitalización de mercado	320.69M
EPS	$-0.240 ( Q1 \| 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 61.14
ATR14	$0.0210 (4.67%)

CRXT -31.16%

MIRA -2.00%

SCLX 7.82%

SCLXW 5.24%

Insider Trading

Date	Person	Action	Amount	type
2023-10-04	Ji Henry	Buy	200 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Shah Jaisim	Buy	200 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Wu Yue Alexander	Buy	250 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Chun Jay	Buy	250 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Ma Stephen Hoi	Buy	150 000	Nonstatutory Stock Option (right to buy)

INSIDER POWER
-88.45
Last 30 transactions
Buy: 13 352 730 \| Sell: 150 694 281

Correlación (AI algo v.1.1b): Overvalued: -0.25% $0.451 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: -0.19 (neutral)

Corto: -0.55 (weak negative)

Signal:(52.69) Neutral

Scilex Holding Company Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Scilex Holding Company Correlación - Moneda/Commodity

-0.24
( neutral )

-0.34
( neutral )

0.00
( neutral )

0.12
( neutral )

0.34
( neutral )

0.23
( neutral )

Scilex Holding Company Finanzas

Annual	2023
Ingresos:	$46.74M
Beneficio Bruto:	$26.92M (57.58 %)
EPS:	$-0.880

FY	2023
Ingresos:	$46.74M
Beneficio Bruto:	$26.92M (57.58 %)
EPS:	$-0.880

FY	2022
Ingresos:	$38.03M
Beneficio Bruto:	$27.24M (71.61 %)
EPS:	$-0.170

Financial Reports:

No articles found.

Scilex Holding Company Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Scilex Holding Company

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company\'s principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase 3 clinical trial to treat lumbosacral radicular pain; SP-103 for the treatment of low back pain, which is in Phase 2 clinical trails; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia that is in Phase 1 clinical trials. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.